北交所市场点评20250731:延续调整,关注AI+、创新药持续性
Western Securities·2025-08-01 07:12

Investment Rating - The report suggests a focus on sectors such as AI hardware and innovative pharmaceuticals, indicating a positive outlook for these areas [3][19]. Core Insights - The market performance on July 31 showed a decrease in trading volume, with the North Exchange A-share trading amount reaching 26.1 billion, down by 0.91 billion from the previous trading day [1][7]. - The North Exchange 50 Index closed at 1422.87, down 1.16%, with a PE_TTM of 66.55 times, while the specialized and innovative index closed at 2432.93, down 1.09% [1][7]. - Among 269 companies listed on the North Exchange, 44 saw an increase in stock prices, while 223 experienced declines, highlighting a mixed performance in the market [1][16]. Summary by Sections Market Review - The North Exchange A-share trading amount was 26.1 billion, a decrease of 0.91 billion from the previous day [1][7]. - The North Exchange 50 Index and specialized index both experienced declines of 1.16% and 1.09%, respectively [1][7]. Stock Performance - Top gainers included Dingjia Precision (479.1%), Guangdao Digital (29.9%), and Fangsheng Co. (15.1%) [1][16]. - Major decliners were Hengli Drilling (-11.4%), Knight Dairy (-7.8%), and Baijia Technology (-7.5%) [1][16]. Important News - The State Council emphasized the implementation of the "Artificial Intelligence +" initiative to promote large-scale commercialization of AI applications [19]. - The National Medical Insurance Bureau has approved over 100 new medical technology pricing projects, facilitating rapid clinical application of brain-computer interface technologies [19]. Company Announcements - Vision Intelligence announced the use of 20 million in idle funds for cash management, with a remaining balance of 99.4 million, representing 36.99% of its audited net assets for 2024 [20]. - Andar Technology plans to repurchase shares using self-raised funds and bank loans, with the proposal approved by the board [22].